These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 5240445)
1. [On the assimilation of the laws on drug specialties in the European common market]. Dittrich S Zahnarztl Mitt; 1968 Apr; 58(7):330. PubMed ID: 5240445 [No Abstract] [Full Text] [Related]
2. Drugs for rare diseases: mixed assessment in Europe. Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539 [TBL] [Abstract][Full Text] [Related]
3. [Patents in the pharmaceutical field: history and development of the institution]. Neri M Boll Chim Farm; 1995; 134(7):364-8. PubMed ID: 7546541 [TBL] [Abstract][Full Text] [Related]
4. [European drug policy]. Sauer F Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [TBL] [Abstract][Full Text] [Related]
5. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality]. Prugnaud JL Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075 [No Abstract] [Full Text] [Related]
6. Draft EU regulation on paediatric medicines: some improvements but still far from perfect. Prescrire Int; 2006 Feb; 15(81):32-3. PubMed ID: 16548115 [TBL] [Abstract][Full Text] [Related]
7. European legislation on flavourings. Food Cosmet Toxicol; 1969 Sep; 7(5):531-3. PubMed ID: 4902882 [No Abstract] [Full Text] [Related]
8. Orphan drug development across Europe: bottlenecks and opportunities. Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178 [TBL] [Abstract][Full Text] [Related]
9. [European legislation on the development of biological similarity: recommendations on the European Agency on Medications with regard to efficacy and safety]. London G Nephrol Ther; 2009 Feb; 5 Spec No1():6-9. PubMed ID: 19233076 [No Abstract] [Full Text] [Related]
10. The legal failure to prevent subclinical developmental toxicity. Cranor C Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):267-73. PubMed ID: 18226082 [TBL] [Abstract][Full Text] [Related]
12. European regulatory guidelines for biosimilars. Wiecek A; Mikhail A Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v17-20. PubMed ID: 16959790 [TBL] [Abstract][Full Text] [Related]
13. [The EEC creates a European Medical Product Agency]. Johnson K Lakartidningen; 1993 Oct; 90(40):3395. PubMed ID: 8231477 [No Abstract] [Full Text] [Related]
14. Quality control of drug prescriptions by positive lists--the European Formulary. Glaeske G Int J Clin Pharmacol Ther; 1994 Aug; 32(8):403-8. PubMed ID: 7981924 [TBL] [Abstract][Full Text] [Related]
16. Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization. van Luijn JC; Gribnau FW; Leufkens HG Br J Clin Pharmacol; 2007 Feb; 63(2):159-62. PubMed ID: 17166187 [TBL] [Abstract][Full Text] [Related]
17. The International Conference on Harmonization common technical document--global submission format? Molzon JA Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749 [No Abstract] [Full Text] [Related]
18. [Ban on antimicrobial growth promoters: a safety advantage for consumers?]. Althaus FR Schweiz Arch Tierheilkd; 1999; 141(3):103-7. PubMed ID: 10095363 [TBL] [Abstract][Full Text] [Related]
19. [The drug trade between European countries and developing countries]. Bruneton C; Naboulet P; van der Heide B; Rey JL Med Trop (Mars); 1997; 57(4):375-9. PubMed ID: 9612781 [TBL] [Abstract][Full Text] [Related]
20. The effect of the European Clinical Trials Directive on published drug research in anaesthesia. Walker E; Hankins MC; White SM Anaesthesia; 2009 Sep; 64(9):984-9. PubMed ID: 19686484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]